Cargando…

P894: A PHASE II TRIAL TO EVALUATE THE EFFICACY OF DARATUMUMAB WITH DCEP IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS WITH EXTRAMEDULLARY DISEASE AFTER BORTEZOMIB BASED TREATMENT

Detalles Bibliográficos
Autores principales: Byun, J. M., Min, C.-K., Kim, K., Bang, S.-M., Lee, J.-J., Kim, J. S., Yoon, S.-S., Koh, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429342/
http://dx.doi.org/10.1097/01.HS9.0000846448.12828.50
_version_ 1784779410543476736
author Byun, J. M.
Min, C.-K.
Kim, K.
Bang, S.-M.
Lee, J.-J.
Kim, J. S.
Yoon, S.-S.
Koh, Y.
author_facet Byun, J. M.
Min, C.-K.
Kim, K.
Bang, S.-M.
Lee, J.-J.
Kim, J. S.
Yoon, S.-S.
Koh, Y.
author_sort Byun, J. M.
collection PubMed
description
format Online
Article
Text
id pubmed-9429342
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94293422022-08-31 P894: A PHASE II TRIAL TO EVALUATE THE EFFICACY OF DARATUMUMAB WITH DCEP IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS WITH EXTRAMEDULLARY DISEASE AFTER BORTEZOMIB BASED TREATMENT Byun, J. M. Min, C.-K. Kim, K. Bang, S.-M. Lee, J.-J. Kim, J. S. Yoon, S.-S. Koh, Y. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429342/ http://dx.doi.org/10.1097/01.HS9.0000846448.12828.50 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Byun, J. M.
Min, C.-K.
Kim, K.
Bang, S.-M.
Lee, J.-J.
Kim, J. S.
Yoon, S.-S.
Koh, Y.
P894: A PHASE II TRIAL TO EVALUATE THE EFFICACY OF DARATUMUMAB WITH DCEP IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS WITH EXTRAMEDULLARY DISEASE AFTER BORTEZOMIB BASED TREATMENT
title P894: A PHASE II TRIAL TO EVALUATE THE EFFICACY OF DARATUMUMAB WITH DCEP IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS WITH EXTRAMEDULLARY DISEASE AFTER BORTEZOMIB BASED TREATMENT
title_full P894: A PHASE II TRIAL TO EVALUATE THE EFFICACY OF DARATUMUMAB WITH DCEP IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS WITH EXTRAMEDULLARY DISEASE AFTER BORTEZOMIB BASED TREATMENT
title_fullStr P894: A PHASE II TRIAL TO EVALUATE THE EFFICACY OF DARATUMUMAB WITH DCEP IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS WITH EXTRAMEDULLARY DISEASE AFTER BORTEZOMIB BASED TREATMENT
title_full_unstemmed P894: A PHASE II TRIAL TO EVALUATE THE EFFICACY OF DARATUMUMAB WITH DCEP IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS WITH EXTRAMEDULLARY DISEASE AFTER BORTEZOMIB BASED TREATMENT
title_short P894: A PHASE II TRIAL TO EVALUATE THE EFFICACY OF DARATUMUMAB WITH DCEP IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS WITH EXTRAMEDULLARY DISEASE AFTER BORTEZOMIB BASED TREATMENT
title_sort p894: a phase ii trial to evaluate the efficacy of daratumumab with dcep in relapsed/refractory multiple myeloma patients with extramedullary disease after bortezomib based treatment
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429342/
http://dx.doi.org/10.1097/01.HS9.0000846448.12828.50
work_keys_str_mv AT byunjm p894aphaseiitrialtoevaluatetheefficacyofdaratumumabwithdcepinrelapsedrefractorymultiplemyelomapatientswithextramedullarydiseaseafterbortezomibbasedtreatment
AT minck p894aphaseiitrialtoevaluatetheefficacyofdaratumumabwithdcepinrelapsedrefractorymultiplemyelomapatientswithextramedullarydiseaseafterbortezomibbasedtreatment
AT kimk p894aphaseiitrialtoevaluatetheefficacyofdaratumumabwithdcepinrelapsedrefractorymultiplemyelomapatientswithextramedullarydiseaseafterbortezomibbasedtreatment
AT bangsm p894aphaseiitrialtoevaluatetheefficacyofdaratumumabwithdcepinrelapsedrefractorymultiplemyelomapatientswithextramedullarydiseaseafterbortezomibbasedtreatment
AT leejj p894aphaseiitrialtoevaluatetheefficacyofdaratumumabwithdcepinrelapsedrefractorymultiplemyelomapatientswithextramedullarydiseaseafterbortezomibbasedtreatment
AT kimjs p894aphaseiitrialtoevaluatetheefficacyofdaratumumabwithdcepinrelapsedrefractorymultiplemyelomapatientswithextramedullarydiseaseafterbortezomibbasedtreatment
AT yoonss p894aphaseiitrialtoevaluatetheefficacyofdaratumumabwithdcepinrelapsedrefractorymultiplemyelomapatientswithextramedullarydiseaseafterbortezomibbasedtreatment
AT kohy p894aphaseiitrialtoevaluatetheefficacyofdaratumumabwithdcepinrelapsedrefractorymultiplemyelomapatientswithextramedullarydiseaseafterbortezomibbasedtreatment